MBA with Professional Certificate in Pharma ESG Analysis

Saturday, 25 April 2026 13:24:27

International Students can apply

Apply Now     Viewbook

MBA with Professional Certificate in Pharma ESG Analysis

Overview

Pharma ESG Analysis

is a specialized field that combines environmental, social, and governance (ESG) principles with the pharmaceutical industry. This MBA with Professional Certificate in Pharma ESG Analysis is designed for professionals who want to understand the impact of ESG factors on the pharma sector.

Learn how to analyze ESG risks and opportunities in the pharma industry, and develop a framework for integrating ESG considerations into business decisions.

Some of the key topics covered in this program include: ESG reporting, stakeholder engagement, and sustainability in pharmaceuticals.

Gain a deeper understanding of the pharma industry's ESG landscape and how to navigate its complexities.

Take the first step towards a more sustainable and responsible future in the pharma industry.

Pharma ESG Analysis is a game-changing combination of business acumen and sustainability expertise, offering a unique MBA with Professional Certificate. This innovative program equips you with the skills to analyze and improve the environmental, social, and governance (ESG) performance of pharmaceutical companies. By mastering Pharma ESG Analysis, you'll gain a competitive edge in the industry, unlocking lucrative career opportunities in corporate social responsibility, sustainability, and finance. With a strong focus on Pharma ESG Analysis, you'll develop a deep understanding of the intersection of business and sustainability, enabling you to drive positive change and create long-term value. (8)

Entry requirements

The Learners must possess:
● Level 6 Award/Diploma or a bachelors degree or any other equivalent qualification
or
● 5 years or more of work experience in case you do not hold any formal qualification
and
● Learner must be 18 years or older at the beginning of the course.


International Students can apply

Joining our world will be life-changing with a student body representing over 157 nationalities.

LSIB is truly an international institution with history of welcoming students from around the world. With us, you're not just a student, you're a member.

Course Content

•
Corporate Social Responsibility (CSR) and Sustainability Reporting •
Environmental, Social, and Governance (ESG) Frameworks and Standards •
Pharma Industry ESG Risks and Opportunities •
Stakeholder Engagement and Communication in ESG Analysis •
ESG Integration in Investment Decisions and Portfolio Management •
Pharmaceutical Company ESG Performance Metrics and Indicators •
Regulatory Requirements and Guidelines for ESG Reporting in Pharma •
ESG Analysis Tools and Methodologies for the Pharma Industry •
Pharmaceutical Supply Chain ESG Risks and Opportunities •
ESG and Sustainability in Pharma Research and Development

Assessment

The evaluation process is conducted through the submission of assignments, and there are no written examinations involved.

Fee and Payment Plans

30 to 40% Cheaper than most Universities and Colleges

Duration

The programme is available in two duration modes:

12 Months: GBP £7700
18 Months: GBP £6700
This programme does not have any additional costs.
The fee is payable in monthly, quarterly, half yearly instalments.
You can avail 5% discount if you pay the full fee upfront in 1 instalment

Payment plans

12 Months - GBP £7700

● Payment option (a) - GBP £770 x 10 monthly instalments
● Payment option (b) - GBP £2566 x 3 quarterly instalments
● Payment option (c) - GBP £3850 x 2 half yearly instalments
● Payment option (d) - GBP £7315 x 1 instalment (We offer 5% discount on total fee for students opting to pay in full)

18 Months - GBP £6700

● Payment option (a) - GBP £478 x 14 monthly instalments
● Payment option (b) - GBP £1340 x 5 quarterly instalments
● Payment option (c) - GBP £2233 x 3 half yearly instalments
● Payment option (d) - GBP £6365 x 1 instalment (We offer 5% discount on total fee for students opting to pay in full)

40% Cheaper

Our course fee is upto 40% cheaper than most universities and colleges.

Apply Now

Accreditation

 Stage 1 (Delivered by LSIB):
The programme involves delivery through on-line Learning Management System (LMS). This stage leads to award of Level 7 Diploma in Strategic Management and Leadership. Credits earned at this stage - 120 credits (60 ECTS).

Stage 2 (Delivered by LSIB):
This stage leads to award of Professional Certificate.

Stage 3 (Delivered by the University / awarding body)
On completion of the diploma programme you progress / Top up with Degree through a UK University for progression to the MBA degree. The stage 3 is delivered via distance learning by faculties from the University / awarding body. Credits earned at this stage - 60 credits (30 ECTS).

Apply Now

  • 1. Complete the online enrolment form and Pay enrolment fee of GBP £10.
  • 2. Wait for our email with course start dates and fee payment plans. Your course starts once you pay the course fee.
  • Apply Now
    •

Got questions? Get in touch

Chat with us: Click the live chat button

+44 75 2064 7455

admissions@lsib.co.uk

+44 (0) 20 3608 0144



Career path

Key facts about MBA with Professional Certificate in Pharma ESG Analysis

The MBA with Professional Certificate in Pharma ESG Analysis is a unique and specialized program that combines the rigors of an MBA with the growing importance of Environmental, Social, and Governance (ESG) analysis in the pharmaceutical industry.
This program is designed to equip students with the knowledge and skills necessary to analyze the ESG performance of pharmaceutical companies and contribute to their sustainability and long-term success.
Through a combination of coursework, case studies, and industry projects, students will learn about the key ESG factors that impact the pharmaceutical industry, including climate change, diversity and inclusion, and corporate governance.
The program will also cover the latest trends and best practices in ESG analysis, as well as the tools and methodologies used to measure and report ESG performance.
Upon completion of the program, students will be able to analyze the ESG performance of pharmaceutical companies, identify areas for improvement, and develop strategies to enhance their sustainability and long-term success.
The program is designed to be completed in 12-18 months, and students will have the opportunity to work on real-world projects and case studies to apply their knowledge and skills.
The industry relevance of this program is high, as the pharmaceutical industry is increasingly recognizing the importance of ESG analysis in driving long-term sustainability and success.
By combining an MBA with a Professional Certificate in Pharma ESG Analysis, students will gain a unique set of skills and knowledge that will make them highly competitive in the job market and prepared to tackle the complex challenges facing the pharmaceutical industry.
The program is designed to be completed by working professionals, and students will have the flexibility to balance their studies with their existing work commitments.
The program is delivered by a team of experienced faculty members who have expertise in ESG analysis, sustainability, and the pharmaceutical industry.
The program is designed to be highly interactive, with a focus on case studies, group projects, and industry presentations.
The program is accredited by a recognized accrediting agency, ensuring that students will receive a high-quality education that is recognized by employers and academic institutions alike.
The program is designed to be affordable, with a range of financing options available to students.
The program is designed to be flexible, with a range of delivery options available, including online and on-campus delivery.
The program is designed to be highly relevant to the job market, with a strong focus on employability and career outcomes.
The program is designed to be highly respected, with a strong reputation among employers and academic institutions.

Why this course?

The significance of an MBA with a Professional Certificate in Pharma ESG Analysis cannot be overstated in today's market. The pharmaceutical industry is under increasing pressure to demonstrate its commitment to environmental, social, and governance (ESG) principles, and companies that fail to do so risk facing reputational damage and financial losses. According to a report by the UK's Pharmaceutical Research and Manufacturers of America (PhRMA), 71% of pharmaceutical companies in the UK have a dedicated ESG team, and 63% have set ESG-related targets. This trend is expected to continue, with the UK's pharmaceutical industry projected to grow by 4.5% annually between 2020 and 2025.
Year ESG-related targets set ESG teams dedicated
2020 55% 45%
2021 62% 53%
2022 71% 63%

Who should enrol in MBA with Professional Certificate in Pharma ESG Analysis?

Ideal Audience for MBA with Professional Certificate in Pharma ESG Analysis Professionals seeking to enhance their knowledge in pharmaceutical industry sustainability and corporate social responsibility, particularly those working in the UK pharmaceutical sector, where 71% of companies have reported a positive impact on their environment and society (Source: PwC UK).
Key Characteristics: - Current professionals in the pharmaceutical industry, including researchers, scientists, and regulatory affairs specialists.
Career Goals: - To gain a deeper understanding of ESG analysis and its application in the pharmaceutical industry, enabling them to make informed decisions that balance business objectives with social and environmental responsibilities.
Background and Experience: - A bachelor's degree in a relevant field, such as life sciences, business, or environmental studies, and at least 2 years of experience in the pharmaceutical industry.